FDA issues emergency use authorization for second at-home COVID-19 treatment
For the second time in as many days, the Food and Drug Administration (FDA) has granted emergency use authorization for an investigational antiviral pill to treat COVID-19. This time it is Merck's molnupiravir.
source https://medicalxpress.com/news/2021-12-fda-issues-emergency-authorization-at-home.html
source https://medicalxpress.com/news/2021-12-fda-issues-emergency-authorization-at-home.html
Comments
Post a Comment